An Ethnographic Study on the Factors Affecting Adherence to Directly Observed Treatment Short-Course in Typical Indian Settings

Neeraj Talukdar, Avinandan Basu, Ravi Mokashi Punekar

Department of Design, IIT Guwahati, Guwahati, India.

DOI: 10.4236/jtr.2015.31003                

Abstract

Efficient management of chronic illness remains a common clinical problem. Non-adherence to a prescribed medical regimen remains a tremendous barrier to the effective medical management of chronic diseases and is considered one of the most serious problems that the medical world faces in the present. Tuberculosis is one such chronic disease which has been a prevalent problem in most of the developing nations, including India. In this paper, we describe an ethnographic study conducted in the state of Assam, with the objective of deciphering the multiple factors that are associated with the failure of the treatment regimen of Tuberculosis, viz. the DOTS (Directly Observed Treatment Short course) programme under RNTCP (Revised National Tuberculosis Control Programme).

Keywords

Adherence, Tuberculosis Treatment, Risk Factors

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	World Health Organization (1997) Treatment of Tuberculosis. Guidelines for National Programmes. 2nd Edition, WHO, Geneva.
[2]	WHO (2014) Global Tuberculosis Report 2014. World Health Organization, Geneva. http://www.who.int/tb/publications/global_report/en/
[3]	Munro, S.A., Lewin, S.A., Smith, H.J., Engel, M.E., Fretheim, A. and Volmink, J. (2007) Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research. PLoS Medicine, 4, e238. http://dx.doi.org/10.1371/journal.pmed.0040238
[4]	Epstein, L.H. and Cluss, P.A. (1982) A Behavioral Medicine Perspective on Adherence to Long-Term Medical Regimens. Journal of Consulting and Clinical Psychology, 50, 950-971. http://dx.doi.org/10.1037/0022-006X.50.6.950
[5]	Sabaté, E., Ed. (2003) Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, Geneva.
[6]	Dunear-Jacob, J., Erlen, J.A., Schlenk, E.A., Ryan, C.M., Sereika, S.M. and Doswell, W.M. (2000) Adherence in Chronic Disease. Annual Review of Nursing Research, 18, 48-90.
[7]	Naing, N.N., D’Este, C., Isa, A.R., Salleh, R., Bakar, N. and Mahmod, M.R. (2001) Factors Contributing to Poor Compliance with Anti-TB Treatment among Tuberculosis Patients. Southeast Asian Journal of Tropical Medicine and Public Health, 32, 369-382.
[8]	O’Boyle, S., Power, J., Ibrahim, M.Y. and Watson, J. (2002) Factors Affecting Patient Compliance with Anti-Tuberculosis Chemotherapy Using the Directly Observed Treatment, Short-Course Strategy (DOTS). The International Journal of Tuberculosis and Lung Disease, 6, 307-312.
[9]	Comolet, T.M., Rakotomalala, R. and Rajaonarioa, H. (1998) Factors Determining Compliance with Tuberculosis Treatment in an Urban Environment, Tamatave, Madagascar. The International Journal of Tuberculosis and Lung Disease, 2, 891-897.
[10]	Liam, C.K., Lim, K.H., Wong, C.M.M. and Tang, B.G. (1999) Attitudes and Knowledge of Newly Diagnosed Tuberculosis Patients Regarding the Disease, and factors Affecting Treatment Compliance. The International Journal of Tuberculosis and Lung Disease, 3, 300-309.
[11]	Galdós Tangüis, H., Caylá, J.A., García de Olalla, P., Jansa, J.M. and Brugal, M.T. (2000) Factors Predicting Non- Completion of Tuberculosis Treatment among HIV-Infected Patients in Barcelona (1987-1996). The International Journal of Tuberculosis and Lung Disease, 4, 55-60.
[12]	Chuah, S.Y. (1991) Factors Associated with Poor Patient Compliance with Antituberculosis Therapy in Northwest Perak, Malaysia. Tubercle, 72, 261-264. http://dx.doi.org/10.1016/0041-3879(91)90051-S
[13]	Cator, M., Brassard, P., Ducic, S. and Culman, K. (2001) Factors Related to Non-Compliance with Active Tuberculosis Treatment in Montreal 1992-1995. Canadian Journal of Public Health Revue Canadienne de Santepublique, 93, 92-97.
[14]	Burman, W.J., Cohn, D.L., Rietmeijer, C.A., Judson, F.N., Sbarbaro, J.A. and Reves, R.R. (1997) Noncompliance With Directly Observed Therapy for Tuberculosis Epidemiology and Effect on the Outcome of Treatment. Chest Journal, 111, 1168-1173. http://dx.doi.org/10.1378/chest.111.5.1168
[15]	Brudney, K. and Dobkin, J. (1991) Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control Programs. American Review of Respiratory Disease, 144, 745- 749. http://dx.doi.org/10.1164/ajrccm/144.4.745
[16]	Al-Hajjaj, M.S. and Al-Khatim, I.M. (2000) High Rate of Non-Compliance with Anti-Tuberculosis Treatment despite a Retrieval System: A Call for Implementation of Directly Observed Therapy in Saudi Arabia. The International Journal of Tuberculosis and Lung Disease, 4, 345-349.
[17]	Balasubramanian, V.N., Oommen, K. and Samuel, R. (2000) DOT or Not? Direct Observation of Anti-Tuberculosis Treatment and Patient Outcomes, Kerala State, India. The International Journal of Tuberculosis and Lung Disease, 4, 409-413.
[18]	Spence, D.P., Hotchkiss, J., Williams, C.S. and Davies, P.D. (1993) Tuberculosis and Poverty. BMJ: British Medical Journal, 307, 759-761. http://dx.doi.org/10.1136/bmj.307.6907.759
[19]	U Box, a Smart Pillbox for TB Treatment. http://innovatorsinhealth.org/solutions/pillbox.shtml
[20]	Batra, S., Ahuja, S., Sinha, A. and Gordon, N. (2012) eCompliance: Enhancing Tuberculosis Treatment with Biometric and Mobile Technology. Proceedings of M4D 2012, New Delhi, 28-29 February 2012, 36.
[21]	Seth, H. and Sorathia, K. (2013) Parichaya—A Low-Cost Device to Increase Adherence among Tuberculosis Patients in Rural Assam. Proceedings of the 11th Asia Pacific Conference on Computer Human Interaction, Bangalore, 24-27 September 2013, 55-62. http://dx.doi.org/10.1145/2525194.2525204
[22]	Krueger, K., Ruby, D., Cooley, P., Montoya, B., Exarchos, A., Djojonegoro, B.M. and Field, K. (2012) Videophone Utilization as an Alternative to Directly Observed Therapy for Tuberculosis (Short Communication). The International Journal of Tuberculosis and Lung Disease, 14, 779-781.
[23]	Udwadia, Z.F. (2001) India’s Multidrug-Resistant Tuberculosis Crisis. Annals of the New York Academy of Sciences, 953, 98-105. http://dx.doi.org/10.1111/j.1749-6632.2001.tb11365.x
[24]	Di Perri, G. and Bonora, S. (2004) Which Agents Should We Use for the Treatment of Multidrug-Resistant Mycobacterium Tuberculosis. Journal of Antimicrobial chemotherapy, 54, 593-602. http://dx.doi.org/10.1093/jac/dkh377